Poseida Therapeutics to Present at the 65th ASH Annual Meeting and Exposition

SAN DIEGO - Poseida Therapeutics, Inc. , a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, today announced the acceptance...

Related Keywords

United States ,San Diego Convention Center ,California ,San Diego ,American ,Sarah Thailing ,Alex Lobo ,Nasdaq ,Details For The Company ,American Society Of Hematology ,Poseida Therapeutics Inc ,Annual Meeting ,Diego Convention Center ,Early Safety Results ,Fully Allogeneic Chimeric Antigen Receptort Cell ,Refractory Multiple Myeloma ,Early Phase ,Investigational Therapies ,Tumor Bearing Murine Xenograft Model ,Artificial Intelligence ,Effective Gene Therapy ,Specific Gene Editing System ,News Publishing ,Markets ,